Who is Fatemeh Ardeshir Larijani, and why is the Trump administration reviewing her immigration status? That question is now becoming a public debate in the US, after viral petitions demanded action against relatives of Iran’s ruling elite living in America.The White House has confirmed it is “reviewing” immigration benefits granted to Iranians under the Biden administration, following online campaigns calling for the deportation of family members of senior Iranian officials. One of the most important names is Fatemeh Ardeshir Larijani, the daughter of Ali Larijani, a powerful figure in Iran’s leadership and the current secretary of the country’s Supreme National Security Council.More than 41,000 people have signed a Change.org petition urging President Donald Trump to deport Ardeshir Larijani. Supporters claim that relatives of Iran’s ruling class should not enjoy life in the US while ordinary Iranians face repression at home.Ali Larijani recently faced backlash after posting online that Trump and Israeli Prime Minister Benjamin Netanyahu were “the main killers of the people of Iran”. His remarks came as Iran’s authorities were accused of killing thousands of protesters during recent unrest.Fatemeh Ardeshir Larijani is a specialised cancer doctor and works at Emory University’s Winship Cancer Institute in Atlanta, Georgia. According to Homeland Security Assistant Secretary Tricia McLaughlin, she was granted a green card in 2021 during Joe Biden’s presidency.“The Trump Administration is reviewing all immigration benefits granted under former Biden administration to aliens from Countries of Concern including Iran,” McLaughlin told Newsweek.Emory University confirmed her employment but declined to comment further on the political row. “We are aware of media coverage regarding one of our physicians,” said Andrea Clement, associate director of public relations at the Winship Cancer Institute.They added: “Emory employees are hired in full compliance with applicable state and federal laws and other applicable requirements, including our commitment to advancing patient care, research, and teaching.”
